Chronic Lymphocytic Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia

Featuring perspectives from Drs Nitin Jain, Anthony Mato, John Pagel and Jennifer Woyach, moderated by Dr John Allan, including the following topics: Introduction (0:00) Front-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) (5:29) Novel Strategies Combining Bruton Tyrosine Kinase (BTK) and Bcl-2 Inhibitors for CLL (29:04) Optimal Management of Adverse Events with BTK and Bcl-2 Inhibitors; Considerations for Special Patient Populations (51:49) Selection and Sequencing of Available Therapies for R/R Disease (1:13:20) Promising Investigational Agents and Strategies (1:37:44) CME information and select publications